SCHEMBL3590152

SCHEMBL3590152

NC(=O)c1c(-c2ccncc2)[nH]c2c1ccc1cnccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC7 O00311 9/20 0.43
▸ DYRK1A Q13627 4/20 0.41
▸ CDK5 Q00535 3/20 0.41
▸ CLK1 P49759 2/20 0.41
▸ CDK5R1 Q15078 2/20 0.41
▸ CDK2 P24941 2/20 0.39
▸ CCNA2 P20248 1/20 0.39
▸ CCNA1 P78396 1/20 0.39
▸ CCNC P24863 2/20 0.39
▸ CDK8 P49336 2/20 0.39
▸ CSNK1D P48730 3/20 0.39
▸ ROCK2 O75116 2/20 0.39
▸ CHEK2 O96017 2/20 0.39
▸ PIM1 P11309 2/20 0.39
▸ PRKACA P17612 2/20 0.39
▸ RPS6KB1 P23443 2/20 0.39
▸ GSK3A P49840 2/20 0.39
▸ PRKCZ Q05513 2/20 0.39
▸ ROCK1 Q13464 2/20 0.39
▸ AURKB Q96GD4 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3597459 0.92 MAP2 (0.48) CDC7DYRK1ACDK5CLK1CDK5R1
SCHEMBL3594823 0.90 CDC7 (0.45) CDC7DYRK1ACDK5CLK1CDK5R1
SCHEMBL3603414 0.88 CDC7 (0.43) CDC7DYRK1ACDK5CDK2CCNA2
SCHEMBL15005797 0.82 CDC7 (0.39) CDC7DYRK1ACDK5CLK1CDK5R1
SCHEMBL3608210 0.81 DHODH (0.44) CDC7DYRK1ACDK5CDK2CSNK1D
SCHEMBL3600494 0.78 CDC7 (0.40) CDC7DYRK1ACDK5CLK1CDK5R1
SCHEMBL3602492 0.77 ERN1 (0.49) CDC7DYRK1ACDK5CDK2CSNK1D
SCHEMBL15005624 0.75 MAP2 (0.42) CDC7DYRK1ACDK5CLK1CDK5R1
SCHEMBL15005240 0.73 CDC7 (0.40) CDC7DYRK1ACDK5CLK1CDK5R1
SCHEMBL15005727 0.69 CDC7 (0.37) CDC7DYRK1ACDK5CLK1CDK5R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2118102-B1 TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES NERVIANO MEDICAL SCIENCES SRL (IT) 2013-06-12 — — EP claimed
US-8207180-B2 Tricyclic indoles and (4,5-dihydro) indoles NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-06-26 — — US claimed
US-20100075998-A1 TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2010-03-25 — — US claimed
EP-2118102-A1 TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES Nerviano Medical Sciences S.r.l. (IT) 2009-11-18 — — EP claimed
WO-2008065054-A1 TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2008-06-05 — — WO claimed
EP-2118102-B1 TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES NERVIANO MEDICAL SCIENCES SRL (IT) 2013-06-12 — — EP disclosed
US-8207180-B2 Tricyclic indoles and (4,5-dihydro) indoles NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-06-26 — — US disclosed
US-20100075998-A1 TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2010-03-25 — — US disclosed
EP-2118102-A1 TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES Nerviano Medical Sciences S.r.l. (IT) 2009-11-18 — — EP disclosed
WO-2008065054-A1 TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2008-06-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100075998-A1 TRICYCLIC INDOLES AND (4,5-DIHYDRO) INDOLES CDC7, CDK7, CDK17 CDC7 1/4885DYRK1A 176/4885CDK5 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback